| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.63 | 0.04 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-06 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |